Evaluation of the Pharmacokinetics and Safety of BLU-5937 in Healthy Adult Japanese and Caucasian Subjects
Clinical trial NCT06179537 · COMPLETED
Trial details
- NCT number
- NCT06179537
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2021-10-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.